×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CGTX – cognition therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CGTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/6
05:33 pm
cgtx
Cognition Therapeutics (NASDAQ:CGTX) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Low
Report
Cognition Therapeutics (NASDAQ:CGTX) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
2/5
07:30 am
cgtx
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Medium
Report
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
2/5
06:09 am
cgtx
Cognition Therapeutics (NASDAQ:CGTX) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Medium
Report
Cognition Therapeutics (NASDAQ:CGTX) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
1/27
07:30 am
cgtx
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
Medium
Report
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
1/6
07:47 am
cgtx
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine's Potential to Slow the Progression of Dementia with Lewy Bodies [Yahoo! Finance]
Low
Report
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine's Potential to Slow the Progression of Dementia with Lewy Bodies [Yahoo! Finance]
1/6
07:30 am
cgtx
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
Low
Report
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
12/5
10:12 am
cgtx
Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? [Yahoo! Finance]
Low
Report
Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? [Yahoo! Finance]
12/4
08:05 am
cgtx
Cognition Therapeutics (NASDAQ:CGTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
Cognition Therapeutics (NASDAQ:CGTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/5
05:28 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Ricciardi Lisa
Medium
Report
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Ricciardi Lisa
2/5
05:27 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Doyle John Brendan
Medium
Report
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Doyle John Brendan
2/5
05:26 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Caggiano Anthony
Medium
Report
Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Caggiano Anthony
1/27
07:37 am
cgtx
Form 8-K COGNITION THERAPEUTICS For: Jan 27
Medium
Report
Form 8-K COGNITION THERAPEUTICS For: Jan 27
12/29
06:02 am
cgtx
Form EFFECT COGNITION THERAPEUTICS
Low
Report
Form EFFECT COGNITION THERAPEUTICS
12/22
04:14 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Ricciardi Lisa
High
Report
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Ricciardi Lisa
12/22
04:11 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Caggiano Anthony
High
Report
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Caggiano Anthony
12/22
04:10 pm
cgtx
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Doyle John Brendan
High
Report
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Doyle John Brendan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: